drugset / Trial / NCT01708889
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study is to determine the effect of renal impairment on pharmacokinetics (PK) of BMS-914143.
Timeline
- Start
- 2012-09
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon Lambda-1a | Protein / enzyme biologic | 180 ug | Subcutaneous |